1. Aguilar M, Chen H, Rivera-Colon G, Niu S, Carrick K, Gwin K, Cuevas HC, Sahoo SS, Li HD, Zhang S, Zheng W, Lucas E (2021) DH C: reliable identification of endometrial precancers through combined Pax2, β-catenin, and Pten immunohistochemistry. Am J Surg Pathol 39:137–147
2. Aguilar M, Chen H, Rivera-Colon G, Niu S, Carrick K, Gwin K, Cuevas IC, Sahoo SS, Li HD, Zhang S, Zheng W, Lucas E, Castrillon DH (2022) Reliable identification of endometrial precancers through combined Pax2, beta-catenin, and Pten immunohistochemistry. Am J Surg Pathol 46:404–414
3. Ahola TM, Alkio N, Manninen T, Ylikomi T (2002) Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells. Endocrinology 143:4620–4626
4. Ai Z, Wang J, Wang Y, Lu L, Tong J, Teng Y (2010) Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway. Cancer 116:3603–3613
5. Ali SH, O’Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P (2000) Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 60:7094–7098